NCT01164709 2019-05-15Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerSwiss Cancer InstitutePhase 1 Completed18 enrolled
NCT00237627 2012-05-18Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast CancerUNC Lineberger Comprehensive Cancer CenterPhase 1/2 Completed107 enrolled